Regenerx Biopharmaceuticals In
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Regenerx Biopharmaceuticals In CS, CUSIP 75886x108.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Regenerx Biopharmaceuticals In CS, CUSIP 75886x108.